Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs Beyond the Rule of 5

被引:146
作者
Sebastiano, Matteo Rossi [1 ]
Doak, Bradley C. [2 ]
Backlund, Maria [3 ]
Poongavanam, Vasanthanathan [1 ]
Over, Bjorn [4 ]
Ermondi, Giuseppe [5 ]
Caron, Giulia [5 ]
Matsson, Par [6 ]
Kihlberg, Jan [1 ]
机构
[1] Uppsala Univ, Dept Chem BMC, Box 576, SE-75123 Uppsala, Sweden
[2] Monash Univ, MIPS, Dept Med Chem, 381 Royal Parade, Parkville, Vic 3052, Australia
[3] Uppsala Univ, Uppsala Univ Drug Optimizat & Pharmaceut Profilin, Dept Pharm, BMC,Sci Life Lab, SE-75123 Uppsala, Sweden
[4] AstraZeneca R&D Gothenburg, Innovat Med & Early Dev Biotech Unit, Cardiovasc & Metab Dis, SE-43183 Molndal, Sweden
[5] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Quarello 15, I-10135 Turin, Italy
[6] Uppsala Univ, BMC, Dept Pharm, Box 580, SE-75123 Uppsala, Sweden
关键词
PASSIVE MEMBRANE-PERMEABILITY; CELL-PERMEABILITY; CACO-2; MONOLAYERS; CYCLIC-PEPTIDES; PHYSICOCHEMICAL PROPERTIES; INTESTINAL-ABSORPTION; ORAL BIOAVAILABILITY; MOLECULAR-PROPERTIES; CLINICAL CANDIDATES; PROTEASE INHIBITORS;
D O I
10.1021/acs.jmedchem.8b00347
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Conformational flexibility has been proposed to significantly affect drug properties outside rule-of-5 (Ro5) chemical space. Here, we investigated the influence of dynamically exposed polarity on cell permeability and aqueous solubility for a structurally diverse set of drugs and clinical candidates far beyond the Ro5, all of which populated multiple distinct conformations as revealed by X-ray crystallography. Efflux-inhibited (passive) Caco-2 cell permeability correlated strongly with the compounds' minimum solvent-accessible 3D polar surface areas (PSA), whereas aqueous solubility depended less on the specific 3D conformation. Inspection of the crystal structures highlighted flexibly linked aromatic side chains and dynamically forming intramolecular hydrogen bonds as particularly effective in providing "chameleonic" properties that allow compounds to display both high cell permeability and aqueous solubility. These structural features, in combination with permeability predictions based on the correlation to solvent-accessible 3D PSA, should inspire drug design in the challenging chemical space far beyond the Ro5.
引用
收藏
页码:4189 / 4202
页数:14
相关论文
共 62 条
  • [51] Structural Biology and Drug Discovery of Difficult Targets: The Limits of Ligandability
    Surade, Sachin
    Blundell, Tom L.
    [J]. CHEMISTRY & BIOLOGY, 2012, 19 (01): : 42 - 50
  • [52] Improving the passive permeability of macrocyclic peptides: Balancing permeability with other physicochemical properties
    Thansandote, Praew
    Harris, Robert M.
    Dexter, Hannah L.
    Simpson, Graham L.
    Pal, Sandeep
    Upton, Richard J.
    Valko, Klara
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (02) : 322 - 327
  • [53] Uchida Masashi, 2009, Journal of Pharmacological and Toxicological Methods, V59, P39, DOI 10.1016/j.vascn.2008.10.006
  • [54] Molecular properties that influence the oral bioavailability of drug candidates
    Veber, DF
    Johnson, SR
    Cheng, HY
    Smith, BR
    Ward, KW
    Kopple, KD
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (12) : 2615 - 2623
  • [55] Villar EA, 2014, NAT CHEM BIOL, V10, P723, DOI [10.1038/NCHEMBIO.1584, 10.1038/nchembio.1584]
  • [56] Exploring experimental and computational markers of cyclic peptides: Charting islands of permeability
    Wang, Conan K.
    Northfield, Susan E.
    Swedberg, Joakim E.
    Colless, Barbara
    Chaousis, Stephanie
    Price, David A.
    Liras, Spiros
    Craik, David J.
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 97 : 202 - 213
  • [57] Rational design and synthesis of an orally bioavailable peptide guided by NMR amide temperature coefficients
    Wang, Conan K.
    Northfield, Susan E.
    Colless, Barbara
    Chaousis, Stephanie
    Hamernig, Ingrid
    Lohman, Rink-Jan
    Nielsen, Daniel S.
    Schroeder, Christina I.
    Liras, Spiros
    Price, David A.
    Fairlie, David P.
    Craik, David J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (49) : 17504 - 17509
  • [58] Macrocycle Conformational Sampling with MacroModel
    Watts, K. Shawn
    Dalal, Pranav
    Tebben, Andrew J.
    Cheney, Daniel L.
    Shelley, John C.
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2014, 54 (10) : 2680 - 2696
  • [59] Preclinical Characterization of BI 201335, a C-Terminal Carboxylic Acid Inhibitor of the Hepatitis C Virus NS3-NS4A Protease
    White, Peter W.
    Llinas-Brunet, Montse
    Amad, Ma'an
    Bethell, Richard C.
    Bolger, Gordon
    Cordingley, Michael G.
    Duan, Jianmin
    Garneau, Michel
    Lagace, Lisette
    Thibeault, Diane
    Kukolj, George
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (11) : 4611 - 4618
  • [60] Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs
    Whitty, Adrian
    Zhong, Mengqi
    Viarengo, Lauren
    Beglov, Dmitri
    Hall, David R.
    Vajda, Sandor
    [J]. DRUG DISCOVERY TODAY, 2016, 21 (05) : 712 - 717